Piperazine

Piperazine

SCHEMBL1317991

C1CNCCN1.CCN(CC)c1ccc2c(-c3ccccc3C(=O)O)c3ccc(=[N+](CC)CC)cc-3oc2c1.[Cl-]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.55
▸ BLM P54132 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ USP2 O75604 1/20 0.55
▸ POLB P06746 1/20 0.55
▸ PPARG P37231 1/20 0.55
▸ RXFP1 Q9HBX9 1/20 0.55
▸ NCOR2 Q9Y618 1/20 0.55
▸ TGM2 P21980 1/20 0.53
▸ FPR2 P25090 4/20 0.52
▸ TLR7 Q9NYK1 1/20 0.46
▸ CHRM1 P11229 1/20 0.45
▸ AVPR2 P30518 4/20 0.45
▸ THRB P10828 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ NPY4R P50391 3/20 0.42
▸ FTO Q9C0B1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL18617 0.95 MEN1 (0.60) MEN1BLMKMT2AUSP2POLB
Hydrochloric Acid SCHEMBL30207638 0.95 MEN1 (0.60) MEN1BLMKMT2AUSP2POLB
Hydrochloric Acid SCHEMBL29354092 0.95 MEN1 (0.60) MEN1BLMKMT2AUSP2POLB
Hydrochloric Acid SCHEMBL10325011 0.94 MEN1 (0.59) MEN1BLMKMT2AUSP2POLB
Hydrochloric Acid SCHEMBL31337069 0.94 MEN1 (0.59) MEN1BLMKMT2AUSP2POLB
SCHEMBL3903552 0.94 MEN1 (0.61) MEN1BLMKMT2AUSP2POLB
SCHEMBL29593395 0.94 MEN1 (0.61) MEN1BLMKMT2AUSP2POLB
Perchlorate SCHEMBL31688153 0.91 MEN1 (0.60) MEN1BLMKMT2AUSP2POLB
Acetic Acid SCHEMBL29510237 0.91 MEN1 (0.60) MEN1BLMKMT2AUSP2POLB
Hydrochloric Acid SCHEMBL3506817 0.90 MEN1 (0.60) MEN1BLMKMT2AUSP2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8771642-B2 Active particles for bio-analytical applications and methods for their preparation Alma Mater Studiorum—Universita' di Bologna (IT) 2014-07-08 — — US disclosed
US-20110274621-A1 Active Particles for Bio-Analytical Applications and Methods for Their Preparation ALMA MATER STUDIORUM-UNIVERSITA'DI BOLOGNA (IT) 2011-11-10 — — US disclosed
EP-2328620-A2 ACTIVE PARTICLES FOR BIO-ANALYTICAL APPLICATIONS AND METHODS FOR THEIR PREPARATION Alma Mater Studiorum - Università di Bologna (IT) 2011-06-08 — — EP disclosed
WO-2010013136-A2 ACTIVE PARTICLES FOR BIO-ANALYTICAL APPLICATIONS AND METHODS FOR THEIR PREPARATION ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2010-02-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110274621-A1 Active Particles for Bio-Analytical Applications and Methods for Their Preparation PHOSPHO1, LIPA, ALG1 MEN1 294/4885BLM 2780/4885KMT2A 3433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback